Medical cannabis company IM Cannabis Corp. IMCC IMCC made its debut on the NASDAQ Capital Market on Monday becoming the first Israeli cannabis company to do so.
Shares experienced volatility on decent volume, closing the day up almost 5%. At the time of the writing of this article on Tuesday, shares were up by 8%.
In an email to Benzinga, IM Cannabis CEO Oren Shuster said he and his team are “extremely proud” to be the first Israeli medical cannabis operator to join the NASDAQ capital market “along with a select group of leading cannabis companies." He added:
“By joining NASDAQ, IMC provides American investors with access and a gateway to investments in the emerging European and Israeli cannabis markets where we have a strong presence and operations. Very few cannabis companies can boast having a decade-long experience in the medical cannabis space and we are leveraging this experience to further propel our international growth into additional high-potential markets."
Earlier this year, IM Cannabis entered the North American market through the acquisition of Canada-based Trichome Financial TFC and its adult-use cannabis operations.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!